News Release Date:
Tuesday, September 22, 2020
Preliminary studies conducted by James Galligan, PhD, an assistant professor at the University of Arizona College of Pharmacy, suggest the enzyme glyoxalase II (GLO2) is a strong candidate for drug developers to consider as a potential treatment for breast cancer and diabetes.
Event Date:
Tuesday, September 22, 2020 (All day)